Ardelyx (ARDX) EBIT (2013 - 2026)
Ardelyx posted quarterly EBIT of -$32.8 million for Q1 2026, up 9.78% year-on-year from -$29.9 million in Q1 2025, and down 743.13% on a QoQ basis from $5.1 million in Q4 2025.
Ardelyx (ARDX) has 14 years of EBIT data on file, last reported at -$32.8 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 9.78% year-over-year to -$32.8 million; the trailing twelve-month figure through Mar 2026 stood at -$37.4 million (up 5.55% YoY), and the FY2025 full-year result was -$41.0 million, down 46.61% from the prior year.
- EBIT for Q1 2026 stood at -$32.8 million, down from $5.1 million in the prior quarter.
- Across five years, EBIT topped out at $12.1 million in Q4 2022 and bottomed at -$36.3 million in Q1 2025.
- The 5-year median for EBIT is -$16.6 million (2023), against an average of -$13.5 million.
- The widest annual swing landed in 2022, when EBIT surged 134.43%; it then plunged 330.47% in 2023.
- A 5-year view of EBIT shows it stood at $12.1 million in 2022, then slumped by 330.47% to -$28.0 million in 2023, then jumped by 129.03% to $8.1 million in 2024, then slumped by 37.24% to $5.1 million in 2025, then sank by 743.13% to -$32.8 million in 2026.
- The last three EBIT figures came in at -$32.8 million (Q1 2026), $5.1 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -32.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.79 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.67 Mn |
| Jun 30, 2025 | -14.40 Mn |
| Mar 31, 2025 | -36.35 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -24.68 Mn |
| Dec 31, 2023 | -27.99 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | -16.62 Mn |
| Mar 31, 2023 | -26.06 Mn |
| Dec 31, 2022 | 12.14 Mn |
| Sep 30, 2022 | -21.88 Mn |
| Jun 30, 2022 | -26.22 Mn |
| Mar 31, 2022 | -27.81 Mn |
| Dec 31, 2021 | -35.27 Mn |
| Sep 30, 2021 | -42.24 Mn |
| Jun 30, 2021 | -44.83 Mn |
| Mar 31, 2021 | -32.01 Mn |
| Dec 31, 2020 | -27.64 Mn |
| Sep 30, 2020 | -17.16 Mn |
| Jun 30, 2020 | -24.21 Mn |
| Mar 31, 2020 | -21.77 Mn |
| Dec 31, 2019 | -18.85 Mn |
| Sep 30, 2019 | -22.09 Mn |
| Jun 30, 2019 | -24.83 Mn |
| Mar 31, 2019 | -25.50 Mn |
| Dec 31, 2018 | -27.38 Mn |
| Sep 30, 2018 | -23.73 Mn |
| Jun 30, 2018 | -22.15 Mn |
| Mar 31, 2018 | -17.69 Mn |
| Dec 31, 2017 | 10.96 Mn |
| Sep 30, 2017 | -21.23 Mn |
| Jun 30, 2017 | -26.42 Mn |
| Mar 31, 2017 | -28.43 Mn |
| Dec 31, 2016 | -31.48 Mn |
| Sep 30, 2016 | -29.20 Mn |
| Jun 30, 2016 | -28.69 Mn |
| Mar 31, 2016 | -23.53 Mn |
| Dec 31, 2015 | -16.88 Mn |
| Sep 30, 2015 | -18.08 Mn |
| Jun 30, 2015 | 9.06 Mn |
| Mar 31, 2015 | -3.49 Mn |
| Dec 31, 2014 | -3.93 Mn |
| Sep 30, 2014 | 81,000.00 |
| Jun 30, 2014 | 2.75 Mn |
| Mar 31, 2014 | -464,000.00 |
| Dec 31, 2013 | -718,000.00 |
| Sep 30, 2013 | -886,000.00 |
| Jun 30, 2013 | -851,000.00 |